TigaTx, Inc.

About TigaTx, Inc.

TigaTx is a company focused on pioneering first-in-class, engineered IgA as neutrophil engagers to fight cancer, with a mission to unleash the tumor-killing power of neutrophils.

Products & Services

Engineered IgA:First-in-class engineered IgA designed as neutrophil engagers to combat cancer.

Specialties

Engineered IgA Neutrophil Engagers Cancer Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 35500000 MR: - FA: up to $35.5 million FAN: 35500000	D: 2024-12-18 FD: 2024-12-18	2 investors

Grant Latest

2024-12-18

$35.5M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

TigaTx, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised